Does Pre-Emptive Availability of PREDICT 2.1 Results Change Ordering Practices for Oncotype DX? A Multi-Center Prospective Cohort Study von Awan, Arif Ali, Saunders, Deanna, Pond, Gregory, Hamm, Caroline, Califaretti, Nadia, Mates, Mihaela, Kumar, Vikaash, Ibrahim, Mohammed F K, Beltran-Bless, Ana-Alicia, Vandermeer, Lisa, Hilton, John, Clemons, Mark

Volltext

Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE) von Schneeweiss, A., Puglisi, F., Peretz-Yablonski, T., Merot, J.-L., Miles, D., Coudert, Bruno, Errihani, Hassan, Dalenc, Florence, Barrett, Sophie, Beato, Carlos, Hu, Xichun, Perrin, Christophe, Ettl, Johannes, Li, Huiping, Cariello, Anna, Frassoldati, Antonio, Wronski, Andrzej, Menjón Beltrán, Salomón, Cicin, Irfan, Schmid, Peter, Juarez, Alejandro, Matos, Erika, Uslu, Ruchan, Wildiers, Hans, Bourgeois, Hugues, von Schumann, Raquel, Wojtukiewicz, Marek, Peron, Yann Izarzugaza, Wheatley, Duncan, De Boer, Richard, Jerusalem, Guy, Latini, Luciano, Barnadas Molins, Agusti, Martinez, Eduardo, Baird, Richard, McCarthy, Nicole, Greil, Richard, Juhasz-Boess, Ingolf, de la Cruz, Luis Ruiz, Del Val, Olga, Azribi, Fathi, Turner, Nicholas, Andrade, Jurandyr, Bernstein, Vanessa, Rayson, Daniel, Gennari, Alessandra, El-Saghir, Nagi, Kukulska, Monika, Pelaez, Ignacio, del Mar Gordon, Maria, Varughese, Mohini, Levitt, Nicola, Singer, Christian, Efremidou, Anna, Evron, Ella, Luigi, Cavanna, Garcia, Andres, Lopez Ceballos, Maria Helena, García, María, Arcediano, Alberto, McAdam, Karen, Humphreys, Alison, de Grève, Jacques, Joy, Anil, Sehdev, Sandeep, Kütner, Riina, Laplaige, Philippe, Christensen, Bernd, Fountzilas, Georgios, Fried, Georgeta, Giacobino, Alice, Bonetti, Andrea, Van der Velden, Annette, Vrijaldenhoven, Suzan, Andres Conejero, Raquel, Murias, Adolfo, Saura, Salvador, Poole, Christopher, Woodward, Natasha, Califaretti, Nadia, Jiang, Jun, Padrik, Peeter, Saarni, Outi, Genet, Dominique, Catala, Stéphanie, Facchini, Thomas, Repp, Roland, Schroeder, Willibald, Kahan, Zsuzsanna, Rosengarten, Ora, Alabiso, Oscar, Van de Wouw, Yes, Sousa, Gabriela, Jesús Florián Jerico, Marta Santisteban, Torrego, Juan Carlos, Rodriguez, Cesar, Llorca, Cristina, Galán, Antonio, Rodríguez, Robinson, Alonso, Isabel

Volltext

Afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one previous trastuzumab treatment... von Harbeck, Nadia, Prof, Huang, Chiun-Sheng, Prof, Hurvitz, Sara, MD, Yeh, Dah-Cherng, MD, Shao, Zhimin, Prof, Im, Seock-Ah, Prof, Jung, Kyung Hae, Prof, Shen, Kunwei, MD, Ro, Jungsil, MD, Jassem, Jacek, Prof, Zhang, Qingyuan, Prof, Im, Young-Hyuck, MD, Wojtukiewicz, Marek, Prof, Sun, Qiang, MD, Chen, Shin-Cheh, Prof, Goeldner, Rainer-Georg, PhD, Uttenreuther-Fischer, Martina, MD, Xu, Binghe, Prof, Piccart-Gebhart, Martine, MD

Volltext

Creating a pragmatic trials program for breast cancer patients: Rethinking Clinical Trials (REaCT) von Basulaiman, Bassam, Awan, Arif Ali, Fergusson, Dean, Vandermeer, Lisa, Arnaout, Angel, Hilton, John, Hutton, Brian, Joy, Anil Abraham, Robinson, Andrew, Califaretti, Nadia, Stober, Carol, Sienkiewicz, Marta, Thavorn, Kednapa, Clemons, Mark

Volltext

Patients' preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 p... von Pivot, X., Gligorov, J., Müller, V., Curigliano, G., Knoop, A., Verma, S., Jenkins, V., Scotto, N., Osborne, S., Fallowfield, L., Fallowfield, Lesley, Jenkins, Valerie, Kilkerr, Justine, Langridge, Carolyn, Monson, Kathryn, Jakobsen, Erik Hugger, Nielsen, Mette Holck, Linnet, Soeren, Knoop, Ann, Pivot, Xavier, Bonnefoi, Herve, Mousseau, Mireille, Zelek, Laurent, Bourgeois, Hugues, Lefeuvre, Claudia Plesse, Bachelot, Thomas, Petit, Thierry, Brain, Etienne, Levy, Christelle, Gligorov, Joseph, Augustin, Doris, Graf, Heiko, Heinrich, Georg, Kroening, Hendrik, Kuemmel, Sherko, Müller, Volkmar, Overkamp, Friedrich, Park-Simon, Tjoung-Won, Schmidt, Marcus, Perlova-Griff, Lidia, Wolf, Christopher, Colleoni, Marco, Ballestrero, Alberto, Bernardo, Antonio, Ribecco, Angela Stefania, Gianni, Luca, Curigliano, Giuseppe, Brewczynska, Elżbieta, Jassem, Jacek, Shirinkin, Vadim, Manikhas, Alexey, Dvornichenko, Victoria, Lichinitser, Mikhail, Semiglazov, Vladimir, Mukhametshina, Guzel, Bulavina, Irina, Arranz, Enrique Espinosa, Ocon, Francisco Carabantes, Vivanco, Guillermo López, Bofill, Javier Salvador, Quintela, Ignacio Porras, Muñoz, Alfonso Sanchez, Pérez, Yolanda Fernández, Espinosa, Javier Cassinello, Alvarez, José Valero, del Prado, Rodrigo Lastra, De Merino, LuisLa Cruz, García, José Manuel Pérez, Frances, Santos Enrech, Edlund, Per, Norberg, Bengt, Wennstig, Anna-Karin, Lind, Pehr, Hauser, Nik, Tausch, Christoph, Camci, Celalettin, Arpaci, Fikret, Abali, Huseyin, Uslu, Ruchan, Tahir, Saad, Wheatley, Duncan, Chan, Stephen, Barrett-Lee, Peter, McAdam, Karen, Simcock, Richard, Burcombe, Russell, El-Maraghi, Robert, Califaretti, Nadia, Spadafora, Silvana, Sehdev, Sandeep, Sami, Amer, Verma, Sunil

Volltext

Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trial von Stockley, Tracy L, Oza, Amit M, Berman, Hal K, Leighl, Natasha B, Knox, Jennifer J, Shepherd, Frances A, Chen, Eric X, Krzyzanowska, Monika K, Dhani, Neesha, Joshua, Anthony M, Tsao, Ming-Sound, Serra, Stefano, Clarke, Blaise, Roehrl, Michael H, Zhang, Tong, Sukhai, Mahadeo A, Califaretti, Nadia, Trinkaus, Mateya, Shaw, Patricia, van der Kwast, Theodorus, Wang, Lisa, Virtanen, Carl, Kim, Raymond H, Razak, Albiruni R A, Hansen, Aaron R, Yu, Celeste, Pugh, Trevor J, Kamel-Reid, Suzanne, Siu, Lillian L, Bedard, Philippe L

Volltext

Abstract P1-19-36: Exploratory analysis of TreatER+ight; a Canadian prospective real-world observational study in HR+ advanced breast cancer von Doyle, Catherine, Califaretti, Nadia, Ferrario, Cristiano, Iqbal, Nayyer, Hilton, John, Vandenberg, Theodore, Mates, Mihaela, Glenns, Vivian, Kulkarni, Swati, Bains, Puneet, Haftchenary, Sina, Perri, Sabrina, Chia, Stephen

Volltext

Abstract PS14-07: Ribociclib + letrozole in patients with hormone receptor-positive (HR+), human epidermal growth factor receptor-2-negative (HER2−) advanced breast cancer (ABC) an... von Cottu, Paul, De Laurentiis, Michelino, Marchetti, Paolo, Coltelli, Luigi, Califaretti, Nadia, Debled, Marc, Patil, Shekar, Evron, Ella, Duhoux, Francois, Menon-Singh, Lakshmi, Wu, Jiwen, Zhou, Katie, Bofill, Javier Salvador

Volltext

Treat ER + ight: Canadian prospective observational study in post-menopausal HR + HER2 - advanced breast cancer women—First interim analysis (IA) von Ferrario, Cristiano, Califaretti, Nadia, Doyle, Catherine, Dent, Susan Faye, Roy, Josee-Anne, Perri, Sabrina R., Chia, Stephen K. L.

Volltext

Leeomic: A comprehensive proteomic analysis towards discovery of predictive patterns of protein expression to ribociclib sensitivity and resistance—A compLEEment-1 Canadian correla... von Chia, Stephen K. L., Henning, Jan-Willem, Warner, Ellen, Song, Xinni, Joy, Anil A., Califaretti, Nadia, Desbiens, Christine, Zarate, Juan Pablo, Haftchenary, Sina, Perri, Sabrina R., Morin, Gregg B.

Volltext

A multi-center pragmatic, randomized, feasibility trial comparing standard of care schedules of filgrastim administration for primary febrile neutropenia prophylaxis in early-stage... von Ibrahim, Mohammed F. K., Hilton, John, Mazzarello, Sasha, Fergusson, Dean, Hutton, Brian, Robinson, Andrew, Califaretti, Nadia, Hsu, Tina, Gertler, Stan, Mates, Mihaela, Stober, Carol, Vandermeer, Lisa, Mallick, Ranjeeta, Clemons, Mark

Volltext

Randomised, phase II, placebo-controlled, trial of fulvestrant plus vandetanib in postmenopausal women with bone only or bone predominant, hormone-receptor-positive metastatic brea... von Clemons, Mark J., Cochrane, Brandy, Pond, Gregory R., Califaretti, Nadia, Chia, Stephen K. L., Dent, Rebecca Alexandra, Song, Xinni, Robidoux, Andre, Parpia, Sameer, Warr, David, Rayson, Daniel, Pritchard, Kathleen I., Levine, Mark N.

Volltext

Treat ER + ight: Treatment of Canadian postmenopausal women with ER + HER2 - advanced breast cancer in the real-world setting with hormone therapy ± targeted therapy von Califaretti, Nadia, Bouganim, Nathaniel, Dent, Susan Faye, Doyle, Catherine, Henning, Jan-Willem, Sampalis, John S, Perri, Sabrina R., Chia, Stephen K. L.

Volltext

A comprehensive metabolic evaluation reveals impaired glucose metabolism and dyslipidemia in breast cancer patients early in the disease trajectory von Bell, Kirsten E, Di Sebastiano, Katie M, Vance, Vivienne, Hanning, Rhona, Mitchell, Andrew, Quadrilatero, Joe, Russell, Caryl, Dubin, Joel A, Bahl, Mala, Califaretti, Nadia, Campbell, Carolyn, Mourtzakis, Marina

Volltext

Low RNA disruption during neoadjuvant chemotherapy predicts pathologic complete response absence in patients with breast cancer von Cazzaniga, Marina Elena, Ademuyiwa, Foluso, Petit, Thierry, Tio, Joke, Generali, Daniele, Ciruelos, Eva M, Califaretti, Nadia, Poirier, Brigitte, Ardizzoia, Antonio, Hoenig, Arnd, Lex, Benno, Mouret-Reynier, Marie-Ange, Giesecke, Dagmar, Isambert, Nicolas, Masetti, Ricardo, Pitre, Lacey, Wrobel, Denise, Augereau, Paule, Milani, Manuela, Rask, Sara, Solbach, Christine, Pritzker, Laura, Noubir, Sanaa, Parissenti, Amadeo, Trudeau, Maureen E

Volltext

Abstract PR03: Molecular profiling of advanced solid tumors at Princess Margaret Cancer Centre and patient outcomes with genotype-matched clinical trials von Bedard, Philippe L., Oza, Amit, Clarke, Blaise, Tsao, Ming-Sound, Leighl, Natasha B., Chen, Eric X., Razak, Albiruni, Berman, Hal K., Serra, Stefano, Roehrl, Michael, Califaretti, Nadia, Trinkaus, Mateya, Zhang, Tong, Sukhai, Mahadeo A., Milea, Anca, Hansen, Aaron R., Pugh, Trevor J., Stockley, Tracy, Kamel-Reid, Suzanne, Siu, Lillian L.

Volltext

Randomised, phase II, placebo-controlled, trial of fulvestrant plus vandetanib in postmenopausal women with bone only or bone predominant, hormone-receptor-positive metastatic brea... von Cochrane, Brandy, Parpia, Sameer, Song, Xinni, Pritchard, Kathleen I, Pond, Gregory R, Califaretti, Nadia, Warr, David, Chia, Stephen K.L, Dent, Rebecca Alexandra, Robidoux, Andre, Levine, Mark N, Clemons, Mark J, Rayson, Daniel

Volltext

Randomized phase II placebo-controlled trial of fulvestrant plus vandetanib in postmenopausal women with bone only or bone predominant, hormone receptor-positive metastatic breast... von Clemons, Mark J., Cochrane, Brandy, Califaretti, Nadia, Chia, Stephen K. L., Dent, Rebecca Alexandra, Song, Xinni, Robidoux, Andre, Pond, Gregory Russell, Parpia, Sameer, Pritchard, Kathleen I., Levine, Mark Norman

Volltext

Tracheobronchial Constriction in Asthmatics Induced by Isocapnic Hyperventilation With Dry Cold Air von Julià-Serdà, Gabriel, Molfino, Néstor A., Califaretti, Nadia, Hoffstein, Victor, Zamel, Noe

Volltext

Additional file 1: of Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trial von Stockley, Tracy, Oza, Amit, Berman, Hal, Leighl, Natasha, Knox, Jennifer, Shepherd, Frances, Chen, Eric, Krzyzanowska, Monika, Neesha Dhani, Joshua, Anthony, Ming-Sound Tsao, Serra, Stefano, Clarke, Blaise, Roehrl, Michael, Zhang, Tong, Mahadeo Sukhai, Califaretti, Nadia, Mateya Trinkaus, Shaw, Patricia, Kwast, Theodorus Van Der, Wang, Lisa, Virtanen, Carl, Kim, Raymond, Albiruni Razak, Hansen, Aaron, Yu, Celeste, Pugh, Trevor, Kamel-Reid, Suzanne, Siu, Lillian, Bedard, Philippe

Volltext bestellen